Recital 9, Regulation (EU) 2021/2282

In forcesince 15 Dec 2021

The European Parliament, in its resolution of 2 March 2017 on EU options for improving access to medicines [OJ C 263, 25.7.2018, p. 4.], called on the Commission to propose legislation on a European system for HTA as soon as possible and to harmonise transparent HTA criteria in order to assess the added therapeutic value and relative effectiveness of health technologies compared with the best available alternative, that takes into account the level of innovation and benefit for patients.